ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 177 filers reported holding ACCELERON PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,743,029 | +69.5% | 19,395 | 0.0% | 0.02% | +127.3% |
| Q4 2019 | $1,028,323 | +34.2% | 19,395 | 0.0% | 0.01% | +22.2% |
| Q3 2019 | $766,296 | -13.8% | 19,395 | -10.4% | 0.01% | -10.0% |
| Q2 2019 | $889,257 | -1.1% | 21,647 | +12.1% | 0.01% | 0.0% |
| Q1 2019 | $899,174 | +18.6% | 19,308 | +10.9% | 0.01% | +11.1% |
| Q4 2018 | $758,031 | -23.9% | 17,406 | 0.0% | 0.01% | -18.2% |
| Q3 2018 | $996,145 | +17.9% | 17,406 | 0.0% | 0.01% | +10.0% |
| Q2 2018 | $845,000 | +24.1% | 17,406 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $681,000 | -7.8% | 17,406 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $739,000 | – | 17,406 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |